Showing results (421-430 of 831) with videos related to
Sort By:
Pageof 84
Cancer|December 7, 2005
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemiaDeborah A Thomas, Andreas H Sarris, Jorge Cortes, et al.Cancer|February 25, 2003
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndromeJorge Cortes, Hagop Kantarjian, Maher Albitar, et al.Cancer|March 11, 2003
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromesApostolia Tsimberidou, Elihu Estey, Jorge Cortes, et al.Cancer|July 16, 2008
Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemiaApostolia-Maria Tsimberidou, Hagop M Kantarjian, Sijin Wen, et al.Cancer|August 20, 2009
The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS?Hagop Kantarjian, Susan O'Brien, Farhad Ravandi, et al.Blood|December 20, 2011
The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivoSabine Ponader, Shih-Shih Chen, Joseph J Buggy, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 22, 2010
Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphomaJennifer L Kelly, Anne J Novak, Zachary S Fredericksen, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2012
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 regionJames R Cerhan, Zachary S Fredericksen, Anne J Novak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemiaTait D Shanafelt, Neil E Kay, Kari G Rabe, et al.Blood Advances|January 4, 2018
Early progression of disease as a predictor of survival in chronic lymphocytic leukemiaInhye E Ahn, Charles M Farber, Matthew S Davids, et al.Pageof 84